Levocetirizine Dihydrochloride Tablet
Product Images NDC 71335-2283

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 71335-2283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352283)

Label (Lbl713352283)
Label for Levocetirizine Dihydrochloride Tablets, USP 5 mg, oral tablet dosage form. The label indicates a package of 10 tablets, repackaged by Bryant Ranch Prepack and manufactured by ScieGen Pharmaceuticals, Inc. It includes storage instructions and warnings about child resistance and administration.*
FDA Label Image

Chemical Structure (Levocetirizine Structure)

Chemical Structure (Levocetirizine Structure)
Chemical structure diagram of levocetirizine dihydrochloride, showing its molecular composition including a chlorophenyl group, piperazine ring, and carboxylic acid moiety with two hydrochloride units.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.